Bone Marrow Microvessel Density and it's Prognostic Significance in AML

Reference

• Lowenberg, B., Downing, J.R. and Burnett, A. (1999) "Acute myeloid leukemia", N. Engl. J. Med., 341, 1051–1062.
   Google Scholar
• Zittoun, R.A., Mandelli, F., Willemze, R., De Witte, D., Labar, B., Resegotti, L., et al. (1995) "Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia", N. Engl. J. Med., 332, 217–223.
   Google Scholar
• Greinix, H.T., Nachbaur, D., Krieger, 0., Eibl, M., Kniibl, P., Kalhs, P., et al. (2002) "Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian stem cell transplantation registry", Br. J. Haematol., 117, 914–923.
   PubMed Web of Science ®Google Scholar
• Buchner, T., Hiddemann, W., Wormann, B., Loftier, H., Gassmann, W., Haferlach, T., etal. (1999) "Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with daunor-ubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group", Blood, 93, 4116–4124.
   PubMed Web of Science ®Google Scholar
• Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., et al. (1998) "The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties", Blood, 92, 2322 — 2333.
   Google Scholar
• Hiddemann, W., Clarkson, B.D., Buchner, T., Melamed, M.R. and Andreeff, M. (1982) "Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute myeloid leukemia", Blood, 59, 216–225.
   Google Scholar
• Estey, E.H., Shen, Y. and Thall, P.F. (2000) "Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB", Blood, 95, 72–77.
   Google Scholar
• Buchner, T., Urbanitz, D., Hiddemann, W., Ruhl, H., Ludwig, W.D., Fischer, J., et al. (1985) "Intensified induction and consolidation with or without maintence chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group", J. Clin. Oncol., 12, 1583–1589.
   Google Scholar
• Kern, W., Haferlach, T., Schoch, C., Löffler, H., Gassmann, W., Heinecke, A., et al. (2003) "Early blast clearance by remission therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial", Blood, 101, 64–70.
   Google Scholar
• Cines, D.B., Pollak, E.S., Buck, C.A., Loscalzo, J., Zimmermann, G.A., McEver, R.P., et al. (1998) "Endothelial cells in physiology and in the pathophysiology of vascular disorders", Blood, 91, 3527–3561.
   Google Scholar
• Follcman, J. (1995) "Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogen-esis", N. Engl. J. Med., 333, 1757— 1763.
   Google Scholar
• Follcman, J. (1971) "Tumor angiogenesis: therapeutic implications", N. Engl. J. Med., 285, 1182 — 1186.
   Google Scholar
• Perez-Atayde, A.R., Sallan, S.E., Tedrow, U., Connors, S., Allred, E. and Follcman, J. (1997) "Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia", Am. J. Pathol., 150, 815–821.
   Web of Science ®Google Scholar
• Aguayo, A., Kantarijan, H., Manshouri, T., Gidel, C., Estey, E., Thomas, D., et al. (2000) "Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes", Blood, 96, 2240–2245.
   Google Scholar
• Hussong, J.W., Rodgers, G.M. and Shami, P.J. (2000) "Evidence of increased angiogenesis in patients with acute myeloid leukemia", Blood, 95, 309–313.
   Google Scholar
• Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., et al. (1999) "Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia", Blood, 94, 3717— 3721.
   Google Scholar
• Litwin, C., Leong, K.G., Zapf, R., Sutherland, H., Naiman, S.C. and Karsan, A. (2002) "Role of microenvironment in promoting angiogenesis in acute myeloid leukemia", Am. J. Hematol., 70, 22–30.
   PubMed Web of Science ®Google Scholar
• Dickson, D.J. and Shami, P.J. (2001) "Angiogenesis in acute and chronic leukemias", Leuk. Lymphoma, 42, 847–853.
   PubMed Web of Science ®Google Scholar
• Thomas, D.A., Giles, F.J., Cortes, J., Cortes, J.E. and Kantarjian, H.M. (2001) "Antiangigenic therapy in leukemia", Acta Haemato-logica, 106, 190–207.
   PubMed Web of Science ®Google Scholar
• Padro, T., Ruiz, S., Bieker, R., Burger, H., Steins, M., Kienast, J., et al. (2000) "Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia", Blood, 95, 2637–2643.
   Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, M.T. et al. (1995) "Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group", Ann. Intern. Med., 103, 620–625.
   Google Scholar
• Perez-Atayde, A.R., Sallan, SE., Tedrow, U., Connors, S., Allred, E. and Follcman, J. (1997) "Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia", Am. J. Pathol., 150, 815–821.
   Web of Science ®Google Scholar
• Pule, M.A., Gullmann, C., Dennis, D., McMahon, C., Jeffers, M. and Smith, 0.P. (2002) "Increased angiogenesis in the bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance", Br. J. Haematol., 118, 991–998.
   PubMed Web of Science ®Google Scholar
• Mesters, R.M., Padro, T., Bicker, R., Steins, M., Kreuter, M., Goner, M., et al. (2001) "Stable remission after administration of the receptor tyrosine lcinase inhibitor 5U5416 in a patient with refractory acute myeloid leukemia", Blood, 98, 241— 243.
   Google Scholar
• Padro, T., Bicker, R., Ruiz, S., Steins, M., Retzlaff, S., Burger, H., et al. (2002) "Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia", Leukemia (Baltimore), 16, 1302— 1310.
   Google Scholar
• Bicker, R., Padro, T., Kramer, J., Steins, M., Kessler, T., Retzlaff, S., et al. (2003) "Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia", Cancer Research, 63, 7241 —7246.
   Google Scholar